3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Brain Neoplasms
5
Radiation Injuries
1
Oligodendroglioma
1
Neurotoxicity Syndromes
1
Neurofibromatosis 1
1
Multiple Myeloma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Glioma
1
Glioblastoma
1
Fatigue
1
Cytokine Release Syndrome
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Breast Neoplasms
1
Astrocytoma
1
Interventions
Lovastatin
3
Deoxycholic Acid
3
AZD 6244
3
pirfenidone
2
Vinblastine
2
Transcranial Direct Current Stimulation
2
Sirolimus
2
Polidocanol
2
Lasers, Solid-State
2
Inhalation
2
Acetylcysteine
2
tipifarnib
1
pomalidomide
1
peginterferon alfa-2b
1
mirdametinib
1
diphenylcyclopropenone
1
binimetinib
1
X-Rays
1
Vincristine
1
Temozolomide
1
Surveys and Questionnaires
1
Sunitinib
1
Specimen Handling
1
Sorafenib
1
Saline Solution
1
Ranibizumab
1
Radiotherapy
1
Photons
1
Pharmacokinetics
1
Neuropsychological Tests
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Neurofibromatosis 1
×
Neuropsychological Tests
×
Clear all
NCT01851135
2016-07-06
NF1-QDV
Nantes University Hospital
Phase NA
Completed
286 enrolled